$9.09
0.434.97%
At Close: -
$9.25
0.161.76%
After Hours: 2:57 PM EDT
15 minutes delayed
ARS Pharmaceuticals
SPRYNASDAQ
ARS Pharmaceuticals (NASDAQ:SPRY) Stock, Insider Trading Activity
ARS Pharmaceuticals: Insider buying and selling updated today.
Institutional Shares Held
15.710M
Institutional Percentage Held
16.2%
| Jun 13, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100K | $9.14 | -$913.92K | SELL | -2.94% | 3.295946M | Jun 11 - Jun 12 | View |
| Jun 13, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100K | $9.14 | -$913.92K | SELL | -2.94% | 3.295946M | Jun 11 - Jun 12 | View |
| May 16, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100K | $9.05 | -$905.44K | SELL | -1.62% | 6.063812M | May 14 - May 16 | View |
| May 16, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100K | $9.05 | -$905.44K | SELL | -1.90% | 5.156346M | May 14 - May 16 | View |
| May 09, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100K | $9.34 | -$934.37K | SELL | -1.61% | 6.113812M | May 07 | View |
| May 09, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100K | $9.34 | -$934.37K | SELL | -1.88% | 5.206346M | May 07 | View |
| Apr 17, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100K | $9.28 | -$928.00K | SELL | -1.65% | 5.975321M | Apr 16 | View |
| Apr 17, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100K | $9.28 | -$928.00K | SELL | -1.91% | 5.125353M | Apr 16 | View |
| Apr 10, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100K | $9.28 | -$927.73K | SELL | -1.63% | 6.025321M | Apr 09 | View |
| Apr 10, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100K | $9.28 | -$927.73K | SELL | -1.90% | 5.175353M | Apr 09 | View |
| Mar 27, 2024 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 1.401299M | $9.48 | $13.29M | BUY | 14.81% | 10.860977M | Mar 25 - Mar 27 | View |
| Mar 26, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -97.61K | $9.12 | -$890.32K | SELL | -1.83% | 5.225353M | Mar 22 - Mar 25 | View |
| Mar 26, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -97.61K | $9.12 | -$890.32K | SELL | -1.58% | 6.075321M | Mar 22 - Mar 25 | View |
| Mar 21, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -2.39K | $9.03 | -$21.57K | SELL | -0.05% | 5.274311M | Mar 19 - Mar 21 | View |
| Mar 21, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -2.39K | $9.03 | -$21.57K | SELL | -0.04% | 6.124279M | Mar 19 - Mar 21 | View |
| Mar 15, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -100K | $9.14 | -$913.68K | SELL | -2.60% | 3.745946M | Mar 13 - Mar 15 | View |
| Mar 15, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -100K | $9.14 | -$913.68K | SELL | -2.60% | 3.745946M | Mar 13 - Mar 15 | View |
| Mar 01, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -3.782K | $9.02 | -$34.10K | SELL | -0.06% | 5.874269M | Feb 29 | View |
| Mar 01, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -3.782K | $9.02 | -$34.10K | SELL | -0.08% | 5.024301M | Feb 29 | View |
| Feb 28, 2024 | Sarina Tanimoto | CHIEF MEDICAL OFFICER | -99.478K | $9.02 | -$897.37K | SELL | -1.66% | 5.875269M | Feb 26 - Feb 28 | View |
| Feb 28, 2024 | Richard Lowenthal | PRESIDENT AND CEO | -99.478K | $9.02 | -$897.37K | SELL | -1.94% | 5.025301M | Feb 26 - Feb 28 | View |
| Oct 02, 2023 | Alexander Fitzpatrick | CHIEF LEGAL OFFICER | 86.258K | $3.71 | $319.95K | BUY | 2905.29% | 89.227K | Sep 28 - Sep 29 | View |
| Sep 25, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 2.7M | $3.03 | $8.18M | BUY | 39.94% | 9.459678M | Sep 21 | View |
| Sep 05, 2023 | Laura Shawver | DIRECTOR | 0 | $4.49 | -$643.52K | SELL-OPTIONS | 0.00% | 210.346K | Sep 01 | View |
| Aug 31, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 3.75M | $6.20 | $23.25M | BUY | 124.60% | 6.759678M | Aug 29 | View |
| Aug 31, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCORBIMED CAPITAL LLC | DIRECTOR | 500K | $6.20 | $3.10M | BUY | 5.90% | 8.971564M | Aug 29 | View |
| Aug 31, 2023 | Peter A Thompson | DIRECTOR | 500K | $6.20 | $3.10M | BUY | 5.90% | 8.971564M | Aug 29 | View |
| Aug 07, 2023 | Laura Shawver | DIRECTOR | 0 | $4.15 | -$259.33K | SELL-OPTIONS | 0.00% | 210.346K | Aug 03 - Aug 04 | View |
| Aug 03, 2023 | Laura Shawver | DIRECTOR | 0 | $4.20 | -$322.00K | SELL-OPTIONS | 0.00% | 210.346K | Aug 01 - Aug 02 | View |
| Jul 07, 2023 | Laura Shawver | DIRECTOR | 0 | $3.82 | -$45.12K | SELL-OPTIONS | 0.00% | 210.346K | Jul 07 | View |
| Jul 06, 2023 | Laura Shawver | DIRECTOR | 0 | $3.87 | -$474.70K | SELL-OPTIONS | 0.00% | 210.346K | Jul 03 - Jul 06 | View |
| Jun 02, 2023 | Laura Shawver | DIRECTOR | 0 | $4.06 | -$557.04K | SELL-OPTIONS | 0.00% | 210.346K | Jun 01 - Jun 02 | View |
| May 10, 2023 | Laura Shawver | DIRECTOR | -43.896K | $3.35 | -$653.58K | SELL | -17.27% | 210.346K | Nov 09 - May 09 | View |
| Dec 01, 2022 | Kathleen Scott | CHIEF FINANCIAL OFFICER | 8.25K | $6.24 | $51.51K | BUY | ∞ | 8.25K | Nov 29 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.